These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 9563663

  • 1. The current role of local intratympanic gentamicin therapy in the management of unilateral Menière's disease.
    Pfleiderer AG.
    Clin Otolaryngol Allied Sci; 1998 Feb; 23(1):34-41. PubMed ID: 9563663
    [Abstract] [Full Text] [Related]

  • 2. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC, Minor LB.
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [Abstract] [Full Text] [Related]

  • 3. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
    Quaranta A, Aloisi A, De Benedittis G, Scaringi A.
    Ann N Y Acad Sci; 1999 Nov 28; 884():410-24. PubMed ID: 10842610
    [Abstract] [Full Text] [Related]

  • 4. Intratympanic gentamicin for intractable Meniere's disease: 5-year follow-up.
    Atlas J, Parnes LS.
    J Otolaryngol; 2003 Oct 28; 32(5):288-93. PubMed ID: 14974857
    [Abstract] [Full Text] [Related]

  • 5. Long-term vertigo control in patients after intratympanic gentamicin instillation for Ménière's disease.
    Bodmer D, Morong S, Stewart C, Alexander A, Chen JM, Nedzelski JM.
    Otol Neurotol; 2007 Dec 28; 28(8):1140-4. PubMed ID: 18084826
    [Abstract] [Full Text] [Related]

  • 6. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ, Fisher LM, Berliner K, Chung J, Green K.
    Otol Neurotol; 2010 Jun 28; 31(4):649-55. PubMed ID: 20431498
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hearing loss following intratympanic instillation of gentamicin for the treatment of unilateral Meniere's disease.
    Kaplan DM, Nedzelski JM, Al-Abidi A, Chen JM, Shipp DB.
    J Otolaryngol; 2002 Apr 28; 31(2):106-11. PubMed ID: 12019738
    [Abstract] [Full Text] [Related]

  • 12. Systematic review of intratympanic gentamicin in Meniere's disease.
    Diamond C, O'Connell DA, Hornig JD, Liu R.
    J Otolaryngol; 2003 Dec 28; 32(6):351-61. PubMed ID: 14967079
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB.
    Am J Otol; 1999 Mar 28; 20(2):209-19. PubMed ID: 10100525
    [Abstract] [Full Text] [Related]

  • 15. Intratympanic gentamycin in severe Ménière's disease.
    Laitakari K.
    Clin Otolaryngol Allied Sci; 1990 Dec 28; 15(6):545-8. PubMed ID: 2073763
    [Abstract] [Full Text] [Related]

  • 16. Preliminary results of a new delivery system for gentamicin to the inner ear in patients with Meniere's disease.
    Thomsen J, Charabi S, Tos M.
    Eur Arch Otorhinolaryngol; 2000 Dec 28; 257(7):362-5. PubMed ID: 11052245
    [Abstract] [Full Text] [Related]

  • 17. Intratympanic gentamicin treatment for Meniere's disease.
    McFeely WJ, Singleton GT, Rodriguez FJ, Antonelli PJ.
    Otolaryngol Head Neck Surg; 1998 May 28; 118(5):589-96. PubMed ID: 9591855
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.